WASIF RIAZ, M.D
Medical Oncology Physician · DAVENPORT, FL
Individual Active NPI 1497929319
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,213 | 429,334 | $24,447,975 | $9,235,130 | $7,344,462 |
| 2023 | 1,157 | 474,546 | $23,569,761 | $8,550,139 | $6,799,926 |
| 2022 | 1,148 | 472,192 | $22,692,292 | $8,484,018 | $6,794,615 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1756 | Injection, iron sucrose, 1 mg | 30,400 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 24,660 | $49 | $39 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 24,480 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 18,000 | $26 | $20 |
| J9271 | Injection, pembrolizumab, 1 mg | 16,200 | $56 | $45 |
| J0185 | Injection, aprepitant, 1 mg | 13,000 | $2 | $1 |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 12,660 | $1 | $1 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 12,540 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 12,389 | $0 | $0 |
| J1434 | Injection, fosaprepitant (focinvez), 1 mg | 7,200 | $3 | $2 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 7,040 | $44 | $35 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,130 | $8 | $6 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | ME119193 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Florida
- NPI 1164881355
- NPI 1144225939
- NPI 1407012602
- NPI 1215101902
- NPI 1861729170
- NPI 1811967243
- NPI 1699778894
- NPI 1184937518
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.